Sign in

CIK 0000887359 · Large accelerated filer

Vericel Corp

Sign in to watch
Ticker
VCEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
MI
Entity type
operating
EIN
943096597
Phone
6175885555
Business address
25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
Former names
AASTROM BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,787,802
in 7 filings, $5.8M under 10b5-1 plans

Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
  2. Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
  3. MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
  4. ZERBE ROBERT L MD −$386K Director sold 19% of stake
  5. SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-10 MICHEL GERARD J CFO and VP, Corp. Development Option exercise · Stock Option (right to buy) −8,750 39,375
2019-05-13 MICHEL GERARD J CFO and VP, Corp. Development Option exercise +17,500 $2.75 $48K 140,172
2019-05-13 MICHEL GERARD J CFO and VP, Corp. Development Sale −17,500 $17.02 $298K 122,672
2019-05-13 MICHEL GERARD J CFO and VP, Corp. Development Option exercise · Stock Option (right to buy) −17,500 48,125
2019-05-01 Rubino Alan L Director Grant or award · Stock Option (right to buy) +13,125 13,125
2019-05-01 Rubino Alan L Director Grant or award · Restricted Stock Unit +1,750 1,750
2019-05-01 MCLAUGHLIN KEVIN F Director Grant or award · Stock Option (right to buy) +13,125 13,125
2019-05-01 MCLAUGHLIN KEVIN F Director Grant or award · Restricted Stock Unit +1,750 1,750
2019-05-01 Hagen Heidi Director Grant or award · Restricted Stock Unit +1,750 1,750
2019-05-01 Hagen Heidi Director Grant or award · Stock Option (right to buy) +13,125 13,125
2019-05-01 GILMAN STEVEN C Director Option exercise +7,500 $2.76 $21K 7,500
2019-05-01 GILMAN STEVEN C Director Sale −7,500 $16.81 $126K 0
2019-05-01 GILMAN STEVEN C Director Option exercise · Stock Option (right to buy) −7,500 0
2019-05-01 GILMAN STEVEN C Director Grant or award · Stock Option (right to buy) +13,125 13,125
2019-05-01 GILMAN STEVEN C Director Grant or award · Restricted Stock Unit +1,750 1,750
2019-05-01 Wotton Paul K Director Grant or award · Stock Option (right to buy) +13,125 13,125
2019-05-01 Wotton Paul K Director Grant or award · Restricted Stock Unit +1,750 1,750
2019-05-01 ZERBE ROBERT L MD Director Grant or award · Stock Option (right to buy) +13,125 13,125
2019-05-01 ZERBE ROBERT L MD Director Grant or award · Restricted Stock Unit +1,750 1,750
2019-04-08 MICHEL GERARD J CFO and VP, Corp. Development Option exercise +4,375 $2.75 $12K 127,047

Page 59 of 75 · 1,497 trades